Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01790126 |
| Title | The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Aragon Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Scottsdale | Arizona | United States | Details | |||
| San Francisco | California | United States | Details | |||
| Chicago | Illinois | United States | Details | |||
| Portland | Oregon | United States | Details | |||
| Seattle | Washington | United States | Details |